NCT06259903View on ClinicalTrials.gov

Subcutaneous Administration of MD-18 in Healthy Subjects

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

April 30, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

MD-18

Subcutaneous Administration of MD-18 in Healthy Subjects.

Trial Locations (1)

522651

Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Cohen Global, Ltd.

INDUSTRY

NCT06259903 - Subcutaneous Administration of MD-18 in Healthy Subjects | Biotech Hunter | Biotech Hunter